Momentum Options Alerts Update for 11/13/2025
Closed Momentum Options Trades for 2025: 50-14 (78%, 17 triple-digit winners) / 2024: 77-17 (82%, 38 triple-digit winners). Please remember, all “Exit Targets” and “Stop Targets” are targets. You should not have any “Stops” entered to close any alerts or “Limit Orders” in your brokerage account unless we list one. We will send out an “Alert” or “New Alert” if we want you to close a position or if a new position comes out. Otherwise, follow instructions at all times in the updates on Monday’s and Thursday’s along with Text Alerts and videos throughout the week.
Special Notice: We have closed three more winners over the past week and our portfolio for directional alerts is very light. This is exactly where we want to be given the current market environment. We have 50 wins for the year with a 78% win rate and 17 triple-digit winners. We always like to have more triple-digit winners than overall losses.
We are still looking to add new alerts that will now have December and January options. We were looking for bigger gains in our Lyft (LYFT) call options but they were set to expire next week. That alert was down over 70% but eventually gave us a profit. We have one older alert with HTZ from September and the newer directional alert for RANI.
Rani Therapeutics (RANI, $2.12, up $0.18)
Option: RANI December 5 calls
Expiration Date: December 19th, 2025
Entry Option Price: 25 cents (11/5/2025)
Current Option Price: $0.15
Exit Target: $0.50
Return: -40%
Stop Target: None
Option: RANI April 5 calls
Expiration Date: April 17th, 2026
Entry Option Price: 38 cents (11/5/2025)
Current Option Price: $0.35
Exit Target: $0.80
Return: -8%
Stop Target: None
Action: Key resistance at $2 was recovered with the high at $2.15. Support is at $1.75-$1.50.
Rani Therapeutics had no revenue until this year and in its latest earnings update it reported a better-than-expected loss but no revenue. The all-time high hit $36.27 on 11/15/21 and shares recently shot up 51% in one session. A golden-cross is in play. If $2.75 clears, there is gap up potential to $4, followed by $6-$7. High risk/ reward as the options will expire worthless if shares remain below $5 into December and April.
The company is developing a proprietary oral delivery technology intended to enable drugs that are injected, to instead be taken orally. This could mean NO MORE SHOTS for many drugs. Any update or approval could send shares zooming.
Hertz Global Holdings (HTZ, $6.34, down $0.04)
Option: HTZ November 9 calls
Expiration Date: November 21st
Entry Option Price: $0.65 (9/25/2025)
Current Option Price: $0.05
Exit Target: $1.30 (Limit Order)
Return: -92%
Stop Target: None
Action: The chart is improving but we are running out of time for HTZ. Let’s hold over the weekend with the slim chance another short covering rally hitting this week.
